Cargando…
Nanotechnology in vaccine delivery()
With very few adjuvants currently being used in marketed human vaccines, a critical need exists for novel immunopotentiators and delivery vehicles capable of eliciting humoral, cellular and mucosal immunity. Such crucial vaccine components could facilitate the development of novel vaccines for viral...
Autores principales: | Peek, Laura J., Middaugh, C. Russell, Berkland, Cory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers, B.V
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103321/ https://www.ncbi.nlm.nih.gov/pubmed/18325628 http://dx.doi.org/10.1016/j.addr.2007.05.017 |
Ejemplares similares
-
Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis
por: Song, Jimmy Y., et al.
Publicado: (2021) -
Yeasts in nanotechnology-enabled oral vaccine and gene delivery
por: Ivanova, Elena
Publicado: (2021) -
Nanotechnological approaches for pentamidine delivery
por: Andreana, Ilaria, et al.
Publicado: (2022) -
Conformational Stability Effect of Polymeric Iron Chelators
por: Qian, Jian, et al.
Publicado: (2019) -
Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
por: Ftouh, Mahdi, et al.
Publicado: (2021)